Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Haluska, P.
168  Ergebnisse:
Personensuche X
?
1

Results of TRIO-14, a phase II, multicenter, randomized, pl..:

Konecny, G.E. ; Hendrickson, A.E. Wahner ; Davidson, T.M....
Gynecologic Oncology.  163 (2021)  3 - p. 465-472 , 2021
Link: https://doi.org/10.1016/..
 
?
2

Prioritizing therapeutic targets using patient-derived xeno..:

Lodhia, K.A. ; Hadley, A.M. ; Haluska, P..
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.  1855 (2015)  2 - p. 223-234 , 2015
Link: https://doi.org/10.1016/..
 
?
3

214 Homologous recombination deficiency (HRD) score and nir..:

Haluska, P. ; Timms, K.M. ; AlHilli, M....
European Journal of Cancer.  50 (2014)  - p. 72-73 , 2014
Link: https://doi.org/10.1016/..
 
?
4

PO3-5: Developing predictive determinants of IGF/INS target..:

Becker, M. ; Hou, X. ; Haluska, P.
Growth Hormone & IGF Research.  24 (2014)  - p. S31 , 2014
Link: https://doi.org/10.1016/..
 
?
5

OP0024 Use of novel patient-derived xenografts and molecula..:

Heong, V. ; Topp, M. ; Rutkowski, R....
European Journal of Cancer.  50 (2014)  - p. e9 , 2014
Link: https://doi.org/10.1016/..
 
?
6

Abstract 2: The development and characterization of ovarian..:

Butler, A. ; Becker, M. ; Weroha, S....
Gynecologic Oncology.  131 (2013)  1 - p. 279-280 , 2013
Link: https://doi.org/10.1016/..
 
?
7

Intrathecal metastases causing conus medullaris syndrome:

Liang, J. J. ; Kizilbash, S. H. ; Haluska, P.
QJM.  107 (2013)  1 - p. 75-75 , 2013
Link: https://doi.org/10.1093/..
 
?
8

OR10-5 Phase I study of figitumumab and pegvisomant in pati..:

Haluska, P. ; Dirksen, U. ; Dudek, A.Z....
Growth Hormone & IGF Research.  22 (2012)  - p. S27 , 2012
Link: https://doi.org/10.1016/..
 
?
9

Ovarian cancer tumorgraft: Viral latency propagates lymphom:

Butler, K. ; Weroha, S. ; Becker, M....
Gynecologic Oncology.  127 (2012)  1 - p. S16 , 2012
Link: https://doi.org/10.1016/..
 
?
10

P01-4 Antitumor effect of ridaforolimus (MK-8669) in combin..:

Hou, X. ; Haines, B. ; Harrington, S....
Growth Hormone & IGF Research.  22 (2012)  - p. S34 , 2012
Link: https://doi.org/10.1016/..
 
?
11

609 A Phase 1 Study of MEDI-573, an Investigational Monoclo..:

Haluska, P. ; Menefee, M.E. ; Plimack, E.R....
European Journal of Cancer.  48 (2012)  - p. 187-188 , 2012
Link: https://doi.org/10.1016/..
 
?
12

P03-11 Quantifying insulin receptor isoform expression in F..:

Harrington, S. ; Weroha, S.J. ; Reynolds, C....
Growth Hormone & IGF Research.  22 (2012)  - p. S75 , 2012
Link: https://doi.org/10.1016/..
 
?
13

P01-9 BMS-754807 and metformin synergistically inhibit brea..:

Becker, M.A. ; Giri, S. ; Finckenstein, F.G....
Growth Hormone & IGF Research.  22 (2012)  - p. S35-S36 , 2012
Link: https://doi.org/10.1016/..
 
?
14

Insulin-like growth factor receptor 1 pathway signature cor..:

Winterhoff, B. ; Haluska, P. ; Kalli, K....
Gynecologic Oncology.  120 (2011)  - p. S71-S72 , 2011
Link: https://doi.org/10.1016/..
 
?
15

Combined erbB/VEGFR blockade has improved anticancer activi..:

Farzan, T. ; Harrington, S. ; Krempski, J....
Gynecologic Oncology.  120 (2011)  - p. S45 , 2011
Link: https://doi.org/10.1016/..
 
1-15